共 333 条
[1]
Beheshti SO(2020)Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects J Am Coll Cardiol 75 2553-2566
[2]
Madsen CM(2020)Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis Circulation 141 1742-1759
[3]
Varbo A(2016)Coronary heart disease, peripheral arterial disease, and stroke in familial hypercholesterolaemia: insights from the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study) Arterioscler Thromb Vasc Biol. 36 2004-10
[4]
Nordestgaard BG(2016)Genetic identification of familial hypercholesterolemia within a single U.S. health care system Science. 354 aaf7000-3490a
[5]
Hu P(2013)Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society Eur Heart J 34 3478-55
[6]
Dharmayat KI(2018)Overview of the current status of familial hypercholesterolaemia care in over 60 countries - the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Atherosclerosis. 277 234-194
[7]
Stevens CAT(2010)Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands Atherosclerosis 209 189-3
[8]
Sharabiani MTA(2021)Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Lancet Lond Engl. S0140–6736 01122-46
[9]
Jones RS(2018)Coronary heart disease mortality in treated familial hypercholesterolaemia: update of the UK Simon Broome FH register Atherosclerosis 274 41-260
[10]
Watts GF(2016)Statins in familial hypercholesterolemia: consequences for coronary artery disease and all-cause mortality J Am Coll Cardiol 68 252-321